Publications by authors named "Srijay S Chenna"

One-component multifunctional sequence-defined ionizable amphiphilic Janus dendrimers (IAJDs) were discovered in our laboratories in 2021 to represent a new class of synthetic vectors for the targeted delivery of messenger RNA (mRNA). They coassemble with mRNA by simple injection of their ethanol solution into a pH 4 acetate buffer containing the nucleic acid into monodisperse dendrimersome nanoparticles (DNPs) with predictable dimensions. DNPs are competitive with 4-component lipid nanoparticles (LNPs), which are used in commercial COVID-19 vaccines, except that IAJDs are prepared in fewer reaction steps than each individual component of the LNPs.

View Article and Find Full Text PDF

Constitutional isomerism has been previously demonstrated by one of our laboratories to represent a powerful design strategy for the elaboration of complex functional self-organizations. Here we report the design, synthesis, and characterization of 14 positional, skeletal, and functional constitutional isomeric one-component, multifunctional, sequence-defined, amphiphilic ionizable Janus dendrimers (IAJDs). Their coassembly by simple injection with luciferase mRNA (Luc-mRNA) to form dendrimersome nanoparticles (DNPs) was studied.

View Article and Find Full Text PDF
Article Synopsis
  • The development of COVID-19 vaccines relied heavily on viral and synthetic vectors, particularly lipid nanoparticles (LNPs) that deliver mRNA effectively.
  • LNPs, made of specific lipid components, co-assemble with mRNA using microfluidic technology and are pivotal in the vaccine formulations by BioNTech/Pfizer and Moderna.
  • A new methodology using ionizable multifunctional amphiphilic Janus dendrimers (IAJDs) enables targeted mRNA delivery through uniquely designed monodisperse nanoparticles, simplifying vaccine production and potentially lowering costs while maintaining effectiveness.
View Article and Find Full Text PDF